Thanks very much for that, Ms. Boudreau.
Through you, Chair, I guess I'm still struggling with understanding this.
We're adding another layer of bureaucracy here. That is what it sounds like to me. Even though we have something that's functioning—the pCPA—and it's negotiating the national prices for medications....
As I said, let's take this medication called metformin as a very specific instance. That price is being negotiated on a national basis for public plans. Why would we need another agency to provide more advice? If there are already negotiations that exist generally for public plans, why would we need more input? I don't understand that. If you could explain it for Canadians, I'd love to hear it.